Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6.
about
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.Linking physiological parameters to perturbations in the human exposome: Environmental exposures modify blood pressure and lung function via inflammatory cytokine pathway.Integrated Network Pharmacology and Metabolomics Analysis of the Therapeutic Effects of Zi Dian Fang on Immune Thrombocytopenic Purpura.
P2860
Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Development and validation of ...... total systemic interleukin-6.
@en
type
label
Development and validation of ...... total systemic interleukin-6.
@en
prefLabel
Development and validation of ...... total systemic interleukin-6.
@en
P2093
P2860
P356
P1476
Development and validation of ...... total systemic interleukin-6.
@en
P2093
Brett Hall
Carrie L Wagner
Derick Siegel
Helgi van de Velde
Jaehong Park
Jessica Vermeulen
Kate Sasser
Man-Cheong Fung
Manjula Reddy
Shalini Chaturvedi
P2860
P304
P356
10.1111/BCP.12652
P407
P577
2015-04-06T00:00:00Z